Future Table of Contents

Future Table of Contents

Volume 25, Number 3 (June 2018)

Perceptions of primary care providers on implementing breast cancer survivorship care
M. Luctkar-Flude, A. Aiken, M.A. McColl, J. Tranmer

Elective Nodal Irradiation or Involved Field Irradiation in Definitive Chemo-radiotherapy of Esophageal Squamous Cell Cancer: A Retrospective Analysis in Clinical N0 Patients
M. Li

Comparing enrolees to non-enrolees of cancer patient navigation at end of life
G.M. Johnston

Head and Neck Cancer Patients Undergoing Radiotherapy: A Bioimpedance Analysis
K. Singh Kohli

How can we better help cancer patients quit smoking? The London Regional Cancer Program experience with smoking cessation
S.M. Davidson, A.V. Louie, R.G. Boldt

Glove and Instrument Handling in Cancer Surgery: A Survey of Surgeons' Beliefs and Practices
D. Berger-Richardson, R.S. Xu, R.A. Gladdy, J.A. McCart, A. Govindarajan, C.J. Swallow

Anastomosing hemangioma of the kidney: radiologic and pathologic distinctions of a kidney cancer
P.M. Cheon

Oncology Education for Canadian Internal Medicine Residents: The Value of Participating in a Medical Oncology Elective Rotation
N.A. Nixon, H. Lim, C. Elser, Y.-J. Ko, R. Lee-Ying, V.C. Tam

Overcoming resistance in a BRAFv600e mutant adenocarcinoma of the lung
T. Schmid, M. Buess

Ode to my Oncologist
C. Heykoop

Rates of Cannabis Use in Patients with Cancer
K. Martell

Medical Oncology Workload in Canada: Infrastructure, Supports, and Delivery of Clinical Care
A. Fundytus, W. Hopman, N. Hammad, J. Biagi, R. Sullivan, V. Vanderpuye, B. Seruga, G. Lopes, M. Sengar, M. Brundage, C. Booth

Harmonization of PD-L1 Testing in Oncology: Canadian Pathology Perspective
D. Ionescu, M. Downes, A. Christofides, M.-S. Tsao

Oncology Education for Internal Medicine Residents: A Call for Action!
T. Younis, B. Colwell

Meeting Report: Canadian Lung Cancer Conference 2018
S.C.M. Lau, Y. Wang, C. Ho, B. Melosky

Comprehensive metastatic lung cancer care must include palliative care
A.M. Rosenblum, M. Chasen

The Survivorship Care Plan: A Valuable Tool for Primary Care Providers?
G. Chaput

Upcoming in Current Oncology

Clinical Practice Guidelines in Breast Cancer- Do they make sense?
N.K. Tyagi, S. Dhesy-Thind

Irreversible Tyrosine Kinase Inhibition of EGFR with Afatinib in EGFR mutation-positive Advanced Non-Small Cell Lung Cancer
S. Morin-Ben Abdallah, V. Hirsh

Brain Metastases in Non-Small Cell Lung Cancer: Are tyrosine kinase inhibitors and checkpoint inhibitors now viable options?
S. Morin-Ben Abdallah, A. Wong

Evaluation of the Delivery of Survivorship Care Plans for South Asian Women Breast Cancer Survivors
S. Singh-Carlson

Anti-angiogenic therapies in non small cell lung cancer
P.M. Ellis, A. Alshangiti, G. Chandhoke

Current Landscape of Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
C.A. Butts

Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer
A. AlFakeeh, C. Brezden-Masley

ALK inhibitors, resistance development, clinical trials
J. Rothenstein, N. Chooback

Circulating Tumour DNA in EGFR-mutant NSCLC: A Review
M. Cabanero, M. Tsao

Real-world patient and caregiver-reported outcomes in advanced breast cancer
V. Lambert-Obry, A.G. Laliberte, A. Castonguay, G. Zanotti, T. Tran, M. Mates, J. Lemieux, P. Chabot, C. Prady, F. Couture, J. Lachaine

Breast cancer screening in 2017
J.M. Seely, T. Alhassan

An algorithm for treatment of squamous non-small cell lung cancer: an evidence-based overview
N. Daaboul, G. Nicholas, S.A. Laurie

Resistance developments to EGFR-TKIs, T790M and Clinical trials
G.M. O'Kane, T.A. Barnes, N.B. Leighl

Advanced Typical and Atypical Carcinoid Tumours of the Lung: Management Guidelines
B. Melosky

Clinical Application and Utility of Genomic Assays in Early Stage Breast Cancer: Key Lessons Learned to Date
S. Chia

Rapidly changing treatment algorithms for metastatic non-squamous NSCLC
B. Melosky

Survival of Patients with Subglottic Squamous Cell Carcinoma
S.D. MacNeil

Is There a Role for Adjuvant Therapy Post Surgery in ‘High Risk for Recurrence’ Kidney Cancer? - An Update on Current Concepts
A. Kapoor

Complementary and alternative medicine use in patients before and after cancer diagnosis
C.A. Buckner, R.M. Lafrenie, J.A. Denommee, J.M. Caswell, D.A. Want

Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients
F. Cavagna, A. Pontes, M. Cavagna, A. Dzik, N.F. Donadio, R. Portela, M.T. Nagai, L.H. Gebrim

Optimising vascular access for patients receiving intravenous systemic therapy for early stage breast cancer – A survey of oncology nurses and physicians
N. Le Vasseur, C. Stober, K. Daigle, A. Robinson, S. McDiarmid, S. Mazzarello, B. Hutton, A. Joy, D. Fergusson, J. Hilton, M. McInnes, M. Clemons

Perceptions around vascular access for intravenous systemic therapy and risk factors for lymphedema in early stage breast cancer – A patient survey
N. LeVasseur, C. Stober, M. Ibrahim, S. Gertler, J. Hilton, A. Robinson, S. McDiarmid, D. Fergusson, S. Mazzarello, B. Hutton, A. Joy, M. McInnes, M. Clemons

Unnecessary variations in practice: how to improve cancer care through pragmatic trials
M. Clemons

Access to care and outcomes for neuroendocrine tumors: does socio-economic status matter?
J. Hallet, N. Coburn, S. Singh, K. Beyfuss, S. Koujanian, N. Liu, C. Law

Baseline Edmonton Symptom Assessment Scale (ESAS) and Survival in Metastatic Renal Cell Carcinoma (mRCC)
J. Graham, J. Gingerich, P. Lambert, A. Alamri, P. Czaykowski

The evolution of biosimilars in oncology, with a focus on trastuzumab
N.A. Nixon, M. Hannouf, S. Verma

Engaging cancer patients in clinical practice guideline development: a pilot study
M.C. Brouwers, M. Vukmirovic, K. Spithoff, C. Zwaal, S. McNair, N. Peek

Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring a BRAF Mutation: A Multicenter Study Exploring Clinical Characteristics, Management and Outcomes in a Real-Life Setting. EXPLORE GFPC 02-14 Study
J.B. Auliac, S. Bayle, A. Vergnenegre, H. le Caer, L. Falchero, R. Gervais, H. Doubre, F. Vinas, B. Marin, C. Chouaid

Geographic variation in surgical practice patterns and outcomes for resected, non-metastatic gastric cancer across Ontario
A. Mahar, A. El-Sedfy, M. Dixon, M. Siddiqui, M. Elmi, A. Ritter, J. Vasilevska-Ristovska, Y. Jeong, L. Helyer, C. Law, B. Zagorski, N. Coburn

Advances in Triple Negative Breast Cancer
J. Lebert, R. Lester, E. Powell, M. Seal, J. McCarthy

Adherence to Guidelines in Requesting OncotypeDX® in a Publicly funded Health Care System
S. Martel

Targeting the PD-1/PD-L1 axis for the treatment of Non-Small Cell Lung Cancer
D.E. Meyers, P.M. Bryan, S. Banerji, D.G. Morris

Are clinical trial eligibility criteria an accurate reflection of a real world population of advanced Non-small cell lung cancer (NSCLC) patients?
K. Al-Baimani, H. Jonker, T. Zhang, G. Goss, S.A. Laurie, G. Nicholas, P. Wheatley-Price

Provincial discordance and cancer drug funding – understanding why
A. Srikanthan, N. Penner, K. Chan, M. Sabharwal, A. Grill

Hormone receptor positive HER2-negative metastatic breast cancer: redrawing the lines
A. Matutino, A.A. Joy, C. Brezden-Masley, S. Chia, S. Verma

Survival outcome differences based on treatment utilization and knowledge of primary tumour site for cancer of unknown Primary (CUP) and known primary patients in Ontario, Canada
C.S Kim, M.B. Hannouf, S. Sarma, G.B. Rodrigues, P.K. Rogan, S.M. Mahmud, E. Winquist, M. Brackstone, G. Zaric

Preoperative bile drainage in periampullary cancer: Impact of a randomized trial
D.J. Kagedan, J.D. Mosko, M.E. Dixon, P.J. Karanicolas, A.C. Wei, N. Goyert, Q. Li, N. Mittmann, N.G. Coburn

CT-quantified body composition predicts short-term outcome following gastrectomy of gastric cancer
Y. Zhang, J. Wang, X. Wang, H. Tian, T. Gao, J. Wang, J. Wang, H. Zheng, L. Zhang, X. Gao, X. Wang, G. Li

First case of sternal replacement with bioceramic prosthesis after radio-induced sarcoma
F. Bertin, E. Deluche, J. Tricard, A. Piccardo, E. Denes

Opportunity is the greatest barrier to providing palliative care to advanced colorectal cancer patients: a survey of oncology clinicians’ perceptions
M.A. Earp

What characterizes cancer family history collection tools? A critical literature review
J.E. Cleophat, H. Nabi, S. Pelletier, K. Bouchard, M. Dorval

Only If You View It with A Different Lens
A. AbuSanad

Eastern Canadian Colorectal Cancer Consensus Conference 2017
S. McGee, W. AlGhareeb, C. Ahmad, D. Armstrong, S. Babak, S. Berry, J. Biagi, C. Booth, D. Bosse, P. Champion, B. Colwell, N. Finn, R. Goel, S. Gray, J. Green, M. Harb, A. Hyde, A. Jeyakumar, D. Jonker, S. Kanagaratnam, P. Kavan, A. MacMillan, A. Muinuddin, P. Nikhilesh, G. Porter, E. Powell, R. Ramjeesingh, M. Raza, S. Rorke, M. Seal, F. Servidio-Italiano, J. Siddiqui, J. Simms, L. Smithson, S. Snow, E. St-Hilaire, T. Stuckless, A. Tate, M. Tehfe, M. Thirlwell, E. Tsvetkova, M. Valdes, M. Vickers, K. Virik, S. Welch, C. Marginean, T. Asmis

Report from the 19th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017
C.A. Kim, S. Ahmed, S. Ahmed, B. Brunet, H. Chalchal, R. Deobald, C. Doll, M. Dupre, V. Gordon, R. Lee-Ying, H. Lim, D. Liu, J. Loree, J.P. McGhie, K. Mulder, J. Park, B. Yip, R. Wong, A. Zaida

Moving Research into Practice: Summary Report of the Ex/Cancer Meeting on Physical Activity, Exercise, and Rehabilitation in Oncology
D. Santa Mina, A. Fong, A.R. Gentile, S.N. Culos-Reed, M. Chasen, C.M. Sabiston

Neoadjuvant Therapy for Breast Cancer: Updates and Proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer
A. Arnaout